Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.977
Filter
1.
J Med Case Rep ; 18(1): 254, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38755694

ABSTRACT

INTRODUCTION: Cervical teratomas are rare congenital neoplasms that can cause neonatal airway obstruction if large. CASE PRESENTATION: The female Persian neonate displayed respiratory distress at birth, with a 7 cm × 8 cm cystic solid mass identified on the left side of the neck. Antenatal ultrasonography revealed polyhydramnios. Despite initial stabilization, the infant required intubation and mechanical ventilation due to persistent respiratory distress. Imaging confirmed a cystic mass compressing the trachea, ruling out cystic hygroma. Surgical resection on postnatal day 17 revealed a 10 cm × 10 cm solid cystic structure, histologically identified as an immature teratoma. CONCLUSION: Despite risks of poor fetal and postnatal outcome from large cervical teratomas, early surgical resection after airway stabilization can result in recovery. Proper multidisciplinary management of respiratory distress from such tumors is paramount.


Subject(s)
Head and Neck Neoplasms , Teratoma , Ultrasonography, Prenatal , Humans , Teratoma/surgery , Teratoma/diagnostic imaging , Teratoma/diagnosis , Teratoma/congenital , Female , Infant, Newborn , Pregnancy , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/surgery , Head and Neck Neoplasms/diagnostic imaging , Head and Neck Neoplasms/congenital , Head and Neck Neoplasms/pathology , Airway Obstruction/etiology , Airway Obstruction/surgery , Airway Obstruction/diagnostic imaging , Polyhydramnios
2.
J Med Case Rep ; 18(1): 232, 2024 May 05.
Article in English | MEDLINE | ID: mdl-38704586

ABSTRACT

BACKGROUND: Mature cystic teratoma co-existing with a mucinous cystadenocarcinoma is a rare tumor that few cases have been reported until now. In these cases, either a benign teratoma is malignantly transformed into adenocarcinoma or a collision tumor is formed between a mature cystic teratoma and a mucinous tumor, which is either primarily originated from epithelial-stromal surface of the ovary, or secondary to a primary gastrointestinal tract tumor. The significance of individualizing the two tumors has a remarkable effect on further therapeutic management. CASE PRESENTATION: In this case, a mature cystic teratoma is co-existed with a mucinous cystadenocarcinoma in the same ovary in a 33-year-old Iranian female. Computed Tomography (CT) Scan with additional contrast of the left ovarian mass suggested a teratoma, whereas examination of resected ovarian mass reported an adenocarcinoma with a cystic teratoma. A dermoid cyst with another multi-septate cystic lesion including mucoid material was revealed in the gross examination of the surgical specimen. Histopathological examination revealed a mature cystic teratoma in association with a well-differentiated mucinous cystadenocarcinoma. The latter showed a CK7-/CK20 + immune profile. Due to the lack of clinical, radiological, and biochemical discoveries attributed to a primary lower gastrointestinal tract tumor, the immune profile proposed the chance of adenocarcinomatous transformation of a benign teratoma. CONCLUSIONS: This case shows the significance of large sampling, precise recording of the gross aspects, histopathological examination, immunohistochemical analysis, and the help of radiological and clinical results to correctly diagnose uncommon tumors.


Subject(s)
Cystadenocarcinoma, Mucinous , Ovarian Neoplasms , Teratoma , Tomography, X-Ray Computed , Humans , Female , Teratoma/pathology , Teratoma/surgery , Teratoma/diagnostic imaging , Teratoma/complications , Teratoma/diagnosis , Adult , Ovarian Neoplasms/pathology , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/surgery , Cystadenocarcinoma, Mucinous/pathology , Cystadenocarcinoma, Mucinous/surgery , Cystadenocarcinoma, Mucinous/diagnosis , Cystadenocarcinoma, Mucinous/diagnostic imaging , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Multiple Primary/surgery
3.
Anticancer Res ; 44(5): 2151-2157, 2024 May.
Article in English | MEDLINE | ID: mdl-38677742

ABSTRACT

BACKGROUND/AIM: While post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) benefits patients with teratoma or viable germ cell tumors (GCT), it becomes overtreatment if necrosis is detected in PC-RPLND specimens. Serum microRNA-371a-3p correctly predicts residual viable GCT with 100% sensitivity; however, prediction of residual teratoma in PC-RPLND specimens using current modalities remains difficult. Therefore, we developed a machine learning model using CT imaging and clinical variables to predict the presence of residual teratoma in PC-RPLND specimens. PATIENTS AND METHODS: This study included 58 patients who underwent PC-RPLND between 2005 and 2019 at the University of Tsukuba Hospital. On CT imaging, 155 lymph nodes were identified as regions of interest (ROIs). The ResNet50 algorithm and/or Support Vector Machine (SVM) classification were applied and a nested, 3-fold cross-validation protocol was used to determine classifier accuracy. RESULTS: PC-RPLND specimen analysis revealed 35 patients with necrosis and 23 patients with residual teratoma, while histology of 155 total ROIs showed necrosis in 84 ROIs and teratoma in 71 ROIs. The ResNet50 algorithm, using CT imaging, achieved a diagnostic accuracy of 80.0%, corresponding to a sensitivity of 67.3%, a specificity of 90.5%, and an AUC of 0.84, whereas SVM classification using clinical variables achieved a diagnostic accuracy of 74.8%, corresponding to a sensitivity of 59.0%, a specificity of 88.1%, and an AUC of 0.84. CONCLUSION: Our machine learning models reliably distinguish between necrosis and residual teratoma in clinical PC-RPLND specimens.


Subject(s)
Lymph Node Excision , Machine Learning , Teratoma , Humans , Male , Adult , Retroperitoneal Space/pathology , Retroperitoneal Space/diagnostic imaging , Retroperitoneal Space/surgery , Teratoma/pathology , Teratoma/surgery , Teratoma/diagnostic imaging , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymph Nodes/diagnostic imaging , Middle Aged , Tomography, X-Ray Computed/methods , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Testicular Neoplasms/diagnostic imaging , Young Adult , Neoplasms, Germ Cell and Embryonal/pathology , Neoplasms, Germ Cell and Embryonal/surgery , Neoplasms, Germ Cell and Embryonal/diagnostic imaging
4.
Afr J Paediatr Surg ; 21(2): 138-140, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38546253

ABSTRACT

ABSTRACT: Gastric teratomas are very rare tumours. They present with upper abdomen distension which can easily be confused with other common conditions with mass per abdomen in the paediatric age group. Surgical excision is curative for gastric teratomas. The diagnosis is confirmed by radiological evaluation followed by histopathological analysis of excised specimen. We are reporting two such cases of gastric teratomas who presented with complaints of upper abdomen distension. They were evaluated with radiological imaging and successfully managed by surgical excision.


Subject(s)
Teratoma , Humans , Child , Radiography , Teratoma/diagnostic imaging , Teratoma/surgery
5.
BMJ Case Rep ; 17(3)2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38490704

ABSTRACT

A term neonate with history of ventriculomegaly in the fetal period was diagnosed with a central nervous system tumour after radiological investigations. It was confirmed as an immature teratoma after histopathological examination. He underwent left frontal craniotomy with tumour excision. Intraoperatively, massive haemorrhage (venous bleed) occurred due to the high vascularity of the tumour and led to haemodynamic instability. A massive transfusion protocol was initiated. Despite multiple transfusions and shock management, he succumbed at 2 weeks of life. This case report highlights the importance of antenatal diagnosis and fetal MRI in prognostication and also the possible role of neoadjuvant chemotherapy in reducing tumour vascularity and, hence, bleeding.


Subject(s)
Brain Neoplasms , Hydrocephalus , Teratoma , Male , Infant, Newborn , Humans , Pregnancy , Female , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Teratoma/diagnostic imaging , Teratoma/surgery , Prenatal Diagnosis , Fetus/pathology
7.
Curr Med Imaging ; 20: 1-7, 2024.
Article in English | MEDLINE | ID: mdl-38389353

ABSTRACT

BACKGROUND: In clinical practice, stem cell transplantation has become an effective method for treating spinal cord nerve injury. Up to now, there has been no report on teratoma caused by transplanted stem cell's abnormal differentiation in the clinic, especially in the analysis of imaging manifestations. Therefore, this article aims to analyze the PET/CT imaging manifestations of teratoma caused by stem cell transplantation to improve the imaging diagnosing capability. CASE PRESENTATION: A patient with a spinal cord injury who had received a stem cell transplant was examined by PET/CT on September 10th, 2020. The PET/CT images of the lesion showed irregular mixed low density on the right side of the erector spinae muscle area at the level of the cervical 3-5 vertebral body, with a maximum cross-section of 9.1×3.9 cm. The 18F-FDG metabolism of the lesion was increased, and the maximum standard uptake value (SUVmax) was 10.7. The boundary was unclear with the third cervical vertebra and cervical 3 and 4-level vertebral plates. Based on the patient's medical history, the lesion was diagnosed as an abnormal proliferative tumor, which was consistent with the pathological examination results. CONCLUSION: To date, there have been no clinical reports on teratomas caused by stem cell transplantation for spinal cord injury at home or abroad. This case report enhances the knowledge of the diagnosis and treatment methods of this type of disease and confirms the diagnostic value of PET/CT examination.


Subject(s)
Spinal Cord Injuries , Teratoma , Humans , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals , Tomography, X-Ray Computed/methods , Teratoma/diagnostic imaging , Teratoma/surgery , Spinal Cord Injuries/diagnostic imaging , Spinal Cord Injuries/surgery , Stem Cell Transplantation , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/surgery
8.
Abdom Radiol (NY) ; 49(4): 1264-1274, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38393356

ABSTRACT

PURPOSE: This study aims to evaluate and identify magnetic resonance (MR) findings of mural nodules to detect squamous cell carcinoma arising from ovarian mature cystic teratoma (SCC-MCT). METHODS: This retrospective study examined 135 patients (SCC-MCTs, n = 12; and benign MCTs, n = 123) with confirmed diagnoses across five different institutions between January 2010 and June 2022. Preoperative MR images for each patient were independently assessed by two experienced radiologists and analyzed following previously reported findings (PRFs): age, tumor size, presence of mural nodules, size of mural nodule, and the angle between mural nodule and cyst wall (acute or obtuse). Furthermore, this study evaluated four mural nodule features-diffusion restriction, fat intensity, Palm tree appearance, and calcification-and the presence of transmural extension. RESULTS: There were significant differences between the SCC-MCT and benign MCT groups in terms of all PRFs and all mural nodule findings (p < 0.01). Among the PRFs, "tumor size" demonstrated the highest diagnostic performance, with a sensitivity of 83.3% and a specificity of 88.6%. A combination of the aforementioned four mural nodule findings showed a sensitivity and specificity of 83.3% and 97.6%, respectively, for the diagnosis of SCC-MCT. Regarding diagnosis based on a combination of four mural nodule findings, the specificity was significantly higher than the diagnosis based on tumor size (p = 0.021). Based on these mural nodule findings, three SCC-MCT patients without transmural invasion could be diagnosed. CONCLUSION: Mural nodule MR findings had a higher diagnostic performance than PRFs for SCC-MCT and can potentially allow early detection of SCC-MCTs.


Subject(s)
Ovarian Neoplasms , Teratoma , Female , Humans , Retrospective Studies , Teratoma/diagnostic imaging , Teratoma/pathology , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Magnetic Resonance Spectroscopy
9.
CNS Oncol ; 13(1): CNS105, 2024 01 01.
Article in English | MEDLINE | ID: mdl-38380555

ABSTRACT

Atypical teratoid rhabdoid tumors (AT/RT) are rare and highly malignant CNS neoplasms primarily affecting children. Adult cases are extremely uncommon, with only approximately 92 reported. Spinal AT/RT in adults is particularly rare. Here, we present the case of a 50-year-old patient diagnosed with AT/RT of the spine. Initially, they were diagnosed and treated for a spinal ependymoma. However, after 10 years, a recurrence was detected through magnetic resonance imaging (MRI) and the tumor was reclassified as AT/RT. We discuss the significance of SMARCB1 gene mutations in diagnosing AT/RT and describe our unique treatment approach involving surgery, radiation and anti-PD1 therapy in this patient.


Atypical teratoid rhabdoid tumors (AT/RT) are rare and serious cancers that affect the brain and spine, and mostly occur in children. AT/RT are rare in adults, with only about 92 cases reported. Our article tells the story of a 50-year-old patient, who was diagnosed with a spinal tumor, initially classified as an ependymoma. Ten years later, the tumor recurred, and was found on routine surveillance imaging. After pathological examination of the recurrent tumor, it was diagnosed as AT/RT. The initial tissue was re-examined, and the original tumor was reclassified as an AT/RT. We explain why a gene called SMARCB1 is important for diagnosing AT/RT. Additionally, we share details about the treatments utilized: including surgery, radiation, and medicines that stimulate the immune system to kill cancer cells. This case highlights the challenges and treatments for this rare cancer in adults.


Subject(s)
Central Nervous System Neoplasms , Rhabdoid Tumor , Teratoma , Humans , Middle Aged , Rhabdoid Tumor/diagnostic imaging , Rhabdoid Tumor/genetics , Rhabdoid Tumor/therapy , SMARCB1 Protein/genetics , Teratoma/diagnostic imaging , Teratoma/genetics , Teratoma/surgery
11.
J Int Med Res ; 52(2): 3000605241232568, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38410854

ABSTRACT

Immature ovarian teratomas are a rare subtype of germ cell tumours characterized by the presence of embryonic elements, particularly primitive neuroepithelium, and they typically affect young women. We report the case of a 20-year-old woman who presented with a growing abdominal mass that turned out to be a grade II immature teratoma after adnexectomy. This article reviews the clinical presentation, imaging features, and some of the main problems that arise in the management of immature ovarian teratomas.


Subject(s)
Ovarian Neoplasms , Teratoma , Humans , Female , Young Adult , Adult , Teratoma/diagnostic imaging , Teratoma/surgery , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/surgery , Ovarian Neoplasms/pathology
12.
J Oral Maxillofac Surg ; 82(5): 590-594, 2024 May.
Article in English | MEDLINE | ID: mdl-38341184

ABSTRACT

Teratomas are congenital malformations that rarely occur in the oral cavity. In the case reported here, fetal magnetic resonance imaging performed at 30 weeks of gestation informed the decision-making of the multidisciplinary management team, who closely followed the pregnancy until the scheduled cesarean delivery at 38 weeks of gestation. After delivery, tracheal intubation was performed to ensure airway patency, and tumor resection was scheduled immediately after ruling out contraindications to surgery based on preoperative examinations, allowing for safe excising of the tumor. Postoperative follow-up at 3 months showed no abnormalities.


Subject(s)
Magnetic Resonance Imaging , Mouth Neoplasms , Teratoma , Humans , Teratoma/congenital , Teratoma/surgery , Teratoma/diagnostic imaging , Teratoma/diagnosis , Female , Pregnancy , Infant, Newborn , Mouth Neoplasms/surgery , Mouth Neoplasms/congenital , Mouth Neoplasms/diagnostic imaging , Mouth Neoplasms/diagnosis , Adult , Prenatal Diagnosis
13.
Childs Nerv Syst ; 40(6): 1953-1956, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38372776

ABSTRACT

Sacrococcygeal teratoma is a congenital tumor of early infancy. Eighty percent are present in the first month of life. It is considered to be an extragonadal germ cell tumor that can be diagnosed in utero. It is considered to be a rare tumor in infancy and childhood. Incidences in girls are more common as compared to boys. Association with other congenital abnormalities of the gastrointestinal system, cardiovascular system, and urological manifestations may be present. Association with spinal dysraphism may be present. A complete systemic evaluation needs to be done before any surgical intervention. We hereby present you a case of a 5-day-old male child, born from a non-consanguineous marriage, who presented to us with a large swelling at the coccygeal region. The mass had a variegated consistency with an ear-like appendage over it with associated hair, bones, and necrotic tissue in it. The patient was evaluated with imaging (MRI) which revealed a heterogeneously enhancing mass at the sacrococcygeal region with mild extension into the pre-sacral space suggesting sacrococcygeal teratoma. After a complete evaluation for congenital abnormal abnormalities of other sites, gross total excision of the mass was performed. The post-operative condition of the baby was uneventful. A biopsy of the mass revealed a mature cystic teratoma. The baby is under follow-up at present.


Subject(s)
Sacrococcygeal Region , Teratoma , Humans , Teratoma/surgery , Teratoma/diagnostic imaging , Teratoma/pathology , Sacrococcygeal Region/pathology , Sacrococcygeal Region/surgery , Sacrococcygeal Region/diagnostic imaging , Male , Infant, Newborn , Magnetic Resonance Imaging
15.
J Surg Res ; 295: 423-430, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38070256

ABSTRACT

INTRODUCTION: Surveillance following sacrococcygeal teratoma (SCT) resection varies. The purpose of this study was to describe the clinical characteristics and outcomes of patients undergoing SCT resection and examine current institutional practices to detect recurrence. METHODS: A single-institution retrospective review of children who underwent resection of an SCT from January 1, 2010 to December 31, 2020 was performed. Data were summarized and surveillance strategies compared between histopathologic subtypes using nonparametric methods. RESULTS: Thirty six patients (75.0% female) underwent SCT removal at a median age of 8 d. Histopathology revealed 27 mature teratomas (75.0%), eight immature teratomas (22.2%), and one malignant germ cell tumor (2.8%). Median postoperative follow-up was 3.17 y (interquartile range [IQR]: 2.31-4.38 y). Patients had a median of 2.32 clinic visits per year (IQR: 2.00-2.70), alpha-fetoprotein levels were obtained at a median of 2.01 times per year (IQR: 0-1.66), and surveillance imaging was performed at a median of 2.31 times per year (IQR: 0-2.84). Patients with immature teratomas had alpha-fetoprotein laboratories obtained more frequently than patients with mature teratomas (3.10 times/year versus 0.93 times/year, P = 0.001). There was no significant difference in the number of imaging studies obtained between groups. Two patients (5.6%) developed recurrence, which were identified on magnetic resonance imaging at 191 and 104 d postresection, respectively. CONCLUSIONS: Postoperative surveillance practices varied widely. Recurrence was noted in a single malignant case in the first year following resection. Multi-institutional studies are needed to determine the optimal surveillance strategy to detect recurrence of SCT.


Subject(s)
Neoplasms, Germ Cell and Embryonal , Pelvic Neoplasms , Teratoma , Child , Humans , Female , Male , alpha-Fetoproteins , Sacrococcygeal Region/pathology , Sacrococcygeal Region/surgery , Teratoma/diagnostic imaging , Teratoma/surgery , Neoplasms, Germ Cell and Embryonal/pathology , Pelvic Neoplasms/pathology
16.
Radiologie (Heidelb) ; 64(1): 26-34, 2024 Jan.
Article in German | MEDLINE | ID: mdl-37947867

ABSTRACT

BACKGROUND: Abnormalities of the ovary are frequently seen on ultrasound examination, sometimes symptomatic, but are more commonly asymptomatic. PURPOSE: Presentation of the most important entities of ovarian masses and their imaging features in infants and children. Discussion of criteria for differentiation between benign and potentially malignant masses. MATERIALS AND METHODS: Review of current literature and presentation of image examples. RESULTS: The most common lesions are ovarian cysts in infants, which usually do not require therapy. Because of the risk of torsion, surgery should be discussed for lesions with a size of 5 cm or more. Benign teratomas represent three-quarters of all solid tumors of the infantile ovary. Malignant masses are rare. The task of imaging is to assess the potential risk of malignancy, also using imaging scores. CONCLUSIONS: Imaging plays a crucial role for therapeutic considerations. Depending on the potential risk, ovarian-sparing surgery is preferred to preserve fertility, as long as the oncologic risk is reasonable.


Subject(s)
Digestive System Abnormalities , Ovarian Cysts , Ovarian Neoplasms , Teratoma , Child , Infant , Female , Humans , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/surgery , Ovarian Cysts/diagnostic imaging , Ovarian Cysts/surgery , Teratoma/diagnostic imaging , Teratoma/surgery , Ovariectomy/methods
18.
Fetal Diagn Ther ; 51(1): 92-100, 2024.
Article in English | MEDLINE | ID: mdl-37725930

ABSTRACT

INTRODUCTION: Fetal intrapericardial teratoma is a rare tumor that can be diagnosed by antenatal ultrasonography early in pregnancy. CASE PRESENTATION: A fetal intrapericardial teratoma was detected on routine ultrasonography in the second trimester of pregnancy. At 31 weeks gestation, a marked increase in tumor size, fetal ascites, and pericardial effusion were observed, indicating that preterm delivery would be inevitable. Corticosteroid prophylaxis (24 mg of betamethasone in two doses of 12 mg 24 h apart) initiated for prophylaxis of respiratory distress syndrome led to a reduction in fetal ascites and pericardial effusion. Betamethasone therapy (4 mg/per day) was continued with the aim to postpone the expected date of delivery. Gestation was extended for more than 2 weeks. At 33 weeks and 5 days gestation, the neonate was delivered by elective cesarean section with ex utero intrapartum treatment and immediately submitted to fetal cardiac surgery. The infant was discharged from the hospital in good health about 4 months later. CONCLUSION: The present report draws attention to improvement in fetal status and extension of gestation achieved with maternal low-dose corticosteroid therapy on antenatal ultrasound finding of fetal ascites and pericardial effusion due to intrapericardial teratoma.


Subject(s)
Heart Neoplasms , Pericardial Effusion , Teratoma , Infant, Newborn , Pregnancy , Humans , Female , Pericardial Effusion/diagnostic imaging , Pericardial Effusion/therapy , Pericardial Effusion/etiology , Cesarean Section , Ascites , Pericardium/diagnostic imaging , Pericardium/pathology , Pericardium/surgery , Ultrasonography, Prenatal/adverse effects , Teratoma/diagnostic imaging , Teratoma/drug therapy , Teratoma/surgery , Adrenal Cortex Hormones , Betamethasone/therapeutic use , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/drug therapy , Heart Neoplasms/surgery
19.
Eur Radiol ; 34(3): 1434-1443, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37672052

ABSTRACT

OBJECTIVES: The histologic subtype of intracranial germ cell tumours (IGCTs) is an important factor in deciding the treatment strategy, especially for teratomas. In this study, we aimed to non-invasively diagnose teratomas based on fractal and radiomic features. MATERIALS AND METHODS: This retrospective study included 330 IGCT patients, including a discovery set (n = 296) and an independent validation set (n = 34). Fractal and radiomic features were extracted from T1-weighted, T2-weighted, and post-contrast T1-weighted images. Five classifiers, including logistic regression, random forests, support vector machines, K-nearest neighbours, and XGBoost, were compared for our task. Based on the optimal classifier, we compared the performance of clinical, fractal, and radiomic models and the model combining these features in predicting teratomas. RESULTS: Among the diagnostic models, the fractal and radiomic models performed better than the clinical model. The final model that combined all the features showed the best performance, with an area under the curve, precision, sensitivity, and specificity of 0.946 [95% confidence interval (CI): 0.882-0.994], 95.65% (95% CI: 88.64-100%), 88.00% (95% CI: 77.78-96.36%), and 91.67% (95% CI: 78.26-100%), respectively, in the test set of the discovery set, and 0.944 (95% CI: 0.855-1.000), 85.71% (95% CI: 68.18-100%), 94.74% (95% CI: 83.33-100%), and 80.00% (95% CI: 58.33-100%), respectively, in the independent validation set. SHapley Additive exPlanations indicated that two fractal features, two radiomic features, and age were the top five features highly associated with the presence of teratomas. CONCLUSION: The predictive model including image and clinical features could help guide treatment strategies for IGCTs. CLINICAL RELEVANCE STATEMENT: Our machine learning model including image and clinical features can non-invasively predict teratoma components, which could help guide treatment strategies for intracranial germ cell tumours (IGCT). KEY POINTS: • Fractals and radiomics can quantitatively evaluate imaging characteristics of intracranial germ cell tumours. • Model combing imaging and clinical features had the best predictive performance. • The diagnostic model could guide treatment strategies for intracranial germ cell tumours.


Subject(s)
Neoplasms, Germ Cell and Embryonal , Teratoma , Humans , Retrospective Studies , Fractals , Diagnosis, Differential , Radiomics , Neoplasms, Germ Cell and Embryonal/diagnostic imaging , Teratoma/diagnostic imaging , Magnetic Resonance Imaging/methods
20.
Clin Genitourin Cancer ; 22(1): 33-37, 2024 02.
Article in English | MEDLINE | ID: mdl-37468341

ABSTRACT

INTRODUCTION: Testicular germ cell tumors are the most common malignancy in young adult males. Patients with metastatic disease receive standard of care chemotherapy followed by retroperitoneal lymph node dissection for residual masses >1cm. However, there is a need for better preoperative tools to discern which patients will have persistent disease after chemotherapy given low rates of metastatic germ cell tumor after chemotherapy. The purpose of this study was to use radiomics to predict which patients would have viable germ cell tumor or teratoma after chemotherapy at time of retroperitoneal lymph node dissection. PATIENTS AND METHODS: Patients with nonseminomatous germ cell tumor undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) between 2008 and 2019 were queried from our institutional database. Patients were included if prechemotherapy computed tomography (CT) scan and postchemotherapy imaging were available. Semiqualitative and quantitative features of residual masses and nodal regions of interest and radiomic feature extractions were performed by 2 board certified radiologists. Radiomic feature analysis was used to extract first order, shape, and second order statistics from each region of interest. Post-RPLND pathology was compared to the radiomic analysis using multiple t-tests. RESULTS: 45 patients underwent PC-RPLND at our institution, with the majority (28 patients) having stage III disease. 24 (53%) patients had teratoma on RPLND pathology, while 2 (4%) had viable germ cell tumor. After chemotherapy, 78%, 53%, and 33% of patients had cystic regions, fat stranding, and local infiltration present on imaging. After radiomic analysis, first order statistics mean, median, 90th percentile, and root mean squares were significant. Strong correlations were observed between these 4 features;a lower signal was associated with positive pathology at RPND. CONCLUSIONS: Testicular radiomics is an emerging tool that may help predict persistent disease after chemotherapy.


Subject(s)
Neoplasms, Germ Cell and Embryonal , Teratoma , Testicular Neoplasms , Male , Young Adult , Humans , Radiomics , Treatment Outcome , Retroperitoneal Space/diagnostic imaging , Neoplasms, Germ Cell and Embryonal/diagnostic imaging , Neoplasms, Germ Cell and Embryonal/drug therapy , Neoplasms, Germ Cell and Embryonal/surgery , Testicular Neoplasms/diagnostic imaging , Testicular Neoplasms/drug therapy , Testicular Neoplasms/surgery , Lymph Node Excision/methods , Teratoma/diagnostic imaging , Teratoma/drug therapy , Teratoma/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...